PMFA
ALXN

Plante Moran Financial Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Plante Moran Financial Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6
Closed -$1K – 887
2020
Q1 		$1K Buy
+6
New +$589 ﹤0.01% 716
2019
Q4 		– Sell
-25
Closed -$2K – 941
2019
Q3 		$2K Hold
25
– – ﹤0.01% 806
2019
Q2 		$3K Sell
25
-3
-11% -$387 ﹤0.01% 713
2019
Q1 		$4K Sell
28
-23
-45% -$2.86K ﹤0.01% 673
2018
Q4 		$5K Buy
51
+22
+76% +$2.6K ﹤0.01% 613
2018
Q3 		$4K Sell
29
-27
-48% -$3.39K ﹤0.01% 626
2018
Q2 		$7K Sell
56
-65
-54% -$7.6K ﹤0.01% 598
2018
Q1 		$13K Buy
121
+56
+86% +$6.69K 0.01% 572
2017
Q4 		$8K Hold
65
– – ﹤0.01% 643
2017
Q3 		$9K Hold
65
– – 0.01% 567
2017
Q2 		$8K Hold
65
– – 0.01% 601
2017
Q1 		$8K Hold
65
– – ﹤0.01% 632
2016
Q4 		$8K Hold
65
– – 0.01% 636
2016
Q3 		$8K Sell
65
-11
-14% -$1.42K 0.01% 630
2016
Q2 		$9K Buy
76
+11
+17% +$1.56K 0.01% 549
2016
Q1 		$9K Hold
65
– – 0.01% 503
2015
Q4 		$12K Sell
65
-47
-42% -$8.21K 0.01% 546
2015
Q3 		$18K Buy
112
+47
+72% +$8.57K 0.01% 396
2015
Q2 		$12K Hold
65
– – 0.01% 503
2015
Q1 		$11K Hold
65
– – 0.01% 509
2014
Q4 		$12K Hold
65
– – 0.01% 507
2014
Q3 		$11K Sell
65
-14
-18% -$2.3K 0.01% 527
2014
Q2 		$12K Buy
79
+65
+464% +$10.3K 0.01% 488
2014
Q1 		$2K Hold
14
– – ﹤0.01% 567
2013
Q4 		$2K Hold
14
– – ﹤0.01% 638
2013
Q3 		$2K Buy
+14
New +$1.54K ﹤0.01% 576

Other funds holding ALXN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Plante Moran Financial Advisors's ALXN Position: Q2 2020 in Review

Plante Moran Financial Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q2 2020, closing a stake of 6 shares — an estimated $1K sold.

Plante Moran Financial Advisors first reported a position in ALXN in Q3 2013 and held it in 26 quarters. The position peaked at $18K in Q3 2015. 705 funds tracked by Wall St. Rank hold ALXN as of Q2 2020.

  • Plante Moran Financial Advisors reported no remaining Alexion Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 6 Alexion Pharmaceuticals shares in Q2 2020, an estimated $1K.
  • Plante Moran Financial Advisors first reported a position in Alexion Pharmaceuticals in Q3 2013 and held it in 26 quarters.
  • Plante Moran Financial Advisors's Alexion Pharmaceuticals position peaked at $18K in Q3 2015.
  • 705 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2020.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.